GlassScriptPhysician profile
Ansley Sellars Powell
NPI 1124613989
$1,034.14
in general payments reported to CMS, 2019-2025
17 companies · $268 in 2025
The $268 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $45.55 · 2022: $314 · 2023: $155 · 2024: $252 · 2025: $268.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $675.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $674.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $200.78 | 2023-2024 | Myfembree |
| Merz North America, INC. | $199.25 | 2025 | |
| Myovant Sciences INC. | $102.84 | 2022 | |
| Scynexis, INC. | $77.54 | 2022 | |
| Exeltis, USA INC. | $76.03 | 2022-2023 | Slynd |
| Astellas Pharma US INC | $75.97 | 2024-2025 | Veozah |
| Sage Therapeutics, LLC | $63.75 | 2024 | |
| Mayne Pharma Commercial LLC | $45.38 | 2024-2025 | |
| Gilead Sciences, INC. | $32.26 | 2023 | |
| Hologic Sales and Service, LLC | $25.79 | 2022 | |
| Agile Therapeutics, INC. | $24.06 | 2021 | |
| Mylan Pharmaceuticals INC. | $21.49 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $21.04 | 2024 | |
| Janssen Pharmaceuticals, INC | $19.99 | 2023 | Xarelto |
| Pfizer INC. | $18.59 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $16.53 | 2022 | |
| Novo Nordisk INC | $12.85 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ansley Powell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.